A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins

被引：11

作者：

Chonira, Vikas ^{[1
]}

Kwon, Young D. ^{[2
]}

Gorman, Jason ^{[2
]}

Case, James Brett ^{[3
]}

Ke, Zhiqiang ^{[4
]}

Simeon, Rudo ^{[1
]}

Cosner, Ryan G. ^{[5
]}

Harris, Darcy R. ^{[2
]}

Olia, Adam S. ^{[2
]}

Stephens, Tyler ^{[6
]}

Shapiro, Lawrence ^{[5
]}

Bender, Michael F. ^{[2
]}

Boyd, Hannah ^{[4
]}

Teng, I-Ting ^{[2
]}

Tsybovsky, Yaroslav ^{[6
]}

Krammer, Florian ^{[7
,8
]}

Zhang, Ningyan ^{[4
]}

Diamond, Michael S. ^{[3
,9
,10
]}

Kwong, Peter D. ^{[2
]}

An, Zhiqiang ^{[4
]}

Chen, Zhilei ^{[1
]}

机构：

[1] Texas A&M Univ, Dept Microbial Pathogenesis & Immunol, Hlth Sci Ctr, Bryan, TX 77807 USA

[2] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[3] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA

[4] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Texas Therapeut Inst, Houston, TX 77030 USA

[5] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA

[6] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Vaccine Res Ctr, Electron Microscopy Unit,Canc Res Technol Program, Frederick, MD USA

[7] Icahn Sch Med Mt Sinai ISMMS, Dept Microbiol, New York, NY USA

[8] ISMMS, Dept Pathol Mol & Cell Based Med, New York, NY USA

[9] Washington Univ, Sch Med, Dept Pathol & Immunol, Dept Mol Microbiol, St Louis, MO 63110 USA

[10] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA

来源：

NATURE CHEMICAL BIOLOGY | 2023年 / 19卷 / 03期

基金：

美国国家卫生研究院;

关键词：

DOMAIN; MODEL; ACE2;

D O I：

10.1038/s41589-022-01193-2

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

We report the engineering and selection of two synthetic proteins-FSR16m and FSR22-for the possible treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. FSR16m and FSR22 are trimeric proteins composed of DARPin SR16m or SR22 fused with a T4 foldon. Despite selection by a spike protein from a now historical SARS-CoV-2 strain, FSR16m and FSR22 exhibit broad-spectrum neutralization of SARS-CoV-2 strains, inhibiting authentic B.1.351, B.1.617.2 and BA.1.1 viruses, with respective IC(50 )values of 3.4, 2.2 and 7.4 ng ml(-1) for FSR16m. Cryo-EM structures revealed that these DARPins recognize a region of the receptor-binding domain (residues 456, 475, 486, 487 and 489) overlapping a critical portion of the angiotensin-converting enzyme 2 (ACE2)-binding surface. K18-hACE2 transgenic mice inoculated with B.1.617.2 and receiving intranasally administered FSR16m showed less weight loss and 10-100-fold lower viral burden in upper and lower respiratory tracts. The strong and broad neutralization potency makes FSR16m and FSR22 promising candidates for the prevention and treatment of infection by SARS-CoV-2.

引用

页码：284 / +

页数：15

共 50 条

[31] SARS-CoV-2 variants of concern: a review
Sarkar, Malay
Madabhavi, Irappa
MONALDI ARCHIVES FOR CHEST DISEASE, 2023, 93 (03)
[32] Immunity to SARS-CoV-2 variants of concern
Altmann, Daniel M.
Boyton, Rosemary J.
Beale, Rupert
SCIENCE, 2021, 371 (6534) : 1103 - 1104
[33] An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern
Du, Wenjuan
Hurdiss, Daniel L.
Drabek, Dubravka
Mykytyn, Anna Z.
Kaiser, Franziska K.
Gonzalez-Hernandez, Mariana
Munoz-Santos, Diego
Lamers, Mart M.
van Haperen, Rien
Li, Wentao
Drulyte, Ieva
Wang, Chunyan
Sola, Isabel
Armando, Federico
Beythien, Georg
Ciurkiewicz, Malgorzata
Baumgartner, Wolfgang
Guilfoyle, Kate
Smits, Tony
van der Lee, Joline
van Kuppeveld, Frank J. M.
van Amerongen, Geert
Haagmans, Bart L.
Enjuanes, Luis
Osterhaus, Albert D. M. E.
Grosveld, Frank
Bosch, Berend-Jan
SCIENCE IMMUNOLOGY, 2022, 7 (73)
[34] SARS-CoV-2 bivalent mRNA vaccine with broad protection against variants of concern
Ma, Qinhai
Li, Man
Ma, Lin
Zhang, Caroline
Zhang, Hong
Zhong, Huiling
Wen, Jian
Wang, Yongsheng
Yan, Zewei
Xiong, Wei
Wu, Linping
Guo, Jianmin
Yang, Wei
Yang, Zifeng
Zhang, Biliang
FRONTIERS IN IMMUNOLOGY, 2023, 14
[35] Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine
Deliyannis, Georgia
Gherardin, Nicholas A.
Wong, Chinn Yi
Grimley, Samantha L.
Cooney, James P.
Redmond, Samuel J.
Ellenberg, Paula
Davidson, Kathryn C.
Mordant, Francesca L.
Smith, Tim
Gillard, Marianne
Lopez, Ester
McAuley, Julie
Tan, Chee Wah
Wang, Jing J.
Zeng, Weiguang
Littlejohn, Mason
Zhou, Runhong
Chan, Jasper Fuk-Woo
Chen, Zhi-wei
Hartwig, Airn E.
Bowen, Richard
Mackenzie, Jason M.
Vincan, Elizabeth
Torresi, Joseph
Kedzierska, Katherine
Pouton, Colin W.
Gordon, Tom P.
Wang, Lin-fa
Kent, Stephen J.
Wheatley, Adam K.
Lewin, Sharon R.
Subbarao, Kanta
Chung, Amy W.
Pellegrini, Marc
Munro, Trent
Nolan, Terry
Rockman, Steven
Jackson, David C.
Purcell, Damian F. J.
Godfrey, Dale I.
EBIOMEDICINE, 2023, 92
[36] Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization
Wang, Guo-Lin
Wang, Zhuang-Ye
Duan, Li-Jun
Meng, Qing-Chuan
Jiang, Ming-Dong
Cao, Jing
Yao, Lin
Zhu, Ka-Li
Cao, Wu-Chun
Ma, Mai-Juan
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (24): : 2354 - 2356
[37] Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern
Tang, Juanjie
Lee, Youri
Ravichandran, Supriya
Grubbs, Gabrielle
Huang, Chang
Stauft, Charles B.
Wang, Tony
Golding, Basil
Golding, Hana
Khurana, Surender
ISCIENCE, 2021, 24 (09)
[38] Hygiene in Dermatology: SARS-CoV-2 and Variants of Concern
Schlatterer, Kathrin
Maxeiner, Horst-Guenter
Zouboulis, Christos C.
Daeschlein, Georg
AKTUELLE DERMATOLOGIE, 2022, 48 (08/09) : 369 - 375
[39] The Emerging Concern and Interest SARS-CoV-2 Variants
Janik, Edyta
Niemcewicz, Marcin
Podogrocki, Marcin
Majsterek, Ireneusz
Bijak, Michal
PATHOGENS, 2021, 10 (06):
[40] On the evolution of SARS-CoV-2 and the emergence of variants of concern
Magiorkinis, Gkikas
TRENDS IN MICROBIOLOGY, 2023, 31 (01) : 5 - 8

← 1 2 3 4 5 →